Imaging of kidney cancer

Radiol Clin North Am. 2007 Jan;45(1):119-47. doi: 10.1016/j.rcl.2006.10.011.

Abstract

Advances in molecular genetics have expanded the understanding of renal cell tumors. Now it is understood that renal cortical tumors are a family of neoplasms with distinct cytogenetics and molecular defects, unique histopathologic features, and different malignant potentials. Imaging contributes to clinical management of patients with renal tumors in providing diagnostic information for tumor detection, characterization, staging, treatment planning, and follow-up.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Transitional Cell / diagnosis
  • Carcinoma, Transitional Cell / diagnostic imaging
  • Carcinoma, Transitional Cell / pathology
  • False Positive Reactions
  • Follow-Up Studies
  • Humans
  • Kidney / pathology
  • Kidney Neoplasms / diagnosis*
  • Kidney Neoplasms / diagnostic imaging
  • Kidney Neoplasms / mortality
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / secondary
  • Kidney Neoplasms / therapy
  • Lymphoma / diagnosis
  • Lymphoma / diagnostic imaging
  • Lymphoma / pathology
  • Magnetic Resonance Imaging*
  • Mesenchymoma / diagnosis
  • Mesenchymoma / diagnostic imaging
  • Mesenchymoma / pathology
  • Middle Aged
  • Neoplasm Staging
  • Positron-Emission Tomography*
  • Time Factors
  • Tomography, X-Ray Computed*
  • Treatment Outcome
  • Ultrasonography*
  • Ultrasonography, Doppler
  • Ultrasonography, Doppler, Color